The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 No. 775

SCHEDULE 8 U.K. Consequential provision

PART 2 U.K. Amendment of secondary legislation

Amendment of the Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015 U.K.

13.—(1) The Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015 M1 are amended as follows.

(2) In regulation 1(4) (citation, commencement and interpretation), insert “ UK ” before “marketing authorisation”.

(3) In regulation 5(2)(c)(i) (exception for medicines indicated for the treatment of persons under 18), insert “ UK ” before “marketing authorisation”.

Commencement Information

I1 Sch. 8 para. 13 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Marginal Citations

M1 S.I. 2015/895.